Albertsons Opioid Lawsuit: Washington Judge Orders $900 Million

What the King County court decided

The court entered final judgment for the State of Washington against Albertsons Companies, Inc. and Safeway, Inc. in case No. 22-2-20910-1 SEA. The state filed the case on 21 December 2022 against Albertsons, Kroger and Rite Aid entities, including Bartell Drugs, QFC and Fred Meyer. By trial every other defendant had settled or been dismissed; the Attorney General's Office says the others settled early or declared bankruptcy.

The bench trial ran from 13 July to 14 September 2026, with 45 witnesses and over 600 exhibits. The court found that between 2006 and 2022 Albertsons dispensed over 640 million opioid pills into Washington, including more than 6.5 million opioid prescriptions, or 61.6% of the total, that triggered at least one recognised red flag of diversion. As a distributor to its own stores, Albertsons never reported a single suspicious order to the Drug Enforcement Administration.

Element of the judgment	Amount or term	Legal basis
Abatement fund	$800 million into a court-supervised trust	Public nuisance, RCW 7.48
Civil penalties	$100 million, or $337,921,650 if the abatement does not stand	Consumer Protection Act, RCW 19.86.140
Costs and attorneys' fees	To be fixed on a petition due within 21 days	RCW 19.86.080(1)
Permanent injunction	Red-flag documentation, staffing, compliance reviews, five years of sworn annual certification	RCW 19.86.080(1)

The legal theory: statutory public nuisance plus consumer protection

Washington pleaded public nuisance as a statutory claim, not a common law tort. Under RCW 7.48.120, a nuisance is unlawfully doing an act, or omitting to perform a duty, that injures or endangers the health or safety of others. The court held that the unlawful element was met because Albertsons breached its duties under the federal Controlled Substances Act and Washington pharmacy law to resolve and document red flags and to block suspicious orders, and it rejected the argument that the state had to prove intent or negligence.

On causation, the judge applied a substantial factor test. Other causes, including manufacturers' marketing, prescribers and illicit fentanyl, did not excuse Albertsons, whose contribution was "very large in absolute terms". The same conduct was held to be unfair practice under the Consumer Protection Act. The approach echoes the use of public nuisance against energy companies, discussed in our report on whether oil companies can be sued for climate change, and the state consumer-protection theory behind the Tennessee trial against Meta.

How the judge arrived at $900 million

The $900 million is a share of an abatement cost the court put at no less than $24 billion and likely closer to $30 billion, plus a reduced penalty. The state's expert had priced a 2026-onward abatement plan at $44.4 billion, revised from an earlier $54.7 billion. The judge accepted some defence critiques but found the plan credible.

At closing the state asked for $2.2 billion of abatement. The judge said the state had not explained that figure and that it was not equitable to make Albertsons pay the whole cost. Weighing the lower abatement cost and Albertsons' contribution, she fixed its share at $800 million. Crucially, she refused any offset for money already paid by other pharmacies, distributors or manufacturers, holding that those settlements were already reflected in ordering only a fraction of the cost and applying Washington's collateral source rule.

The penalty arithmetic is unusually transparent. The court counted 11,953 distribution violations at $2,000 each, the pre-2021 statutory maximum under RCW 19.86.140, and 6,280,313 dispensing violations at $50 each, giving $337,921,650. It noted that Albertsons took in at least $296,025,684 on red-flagged prescriptions dispensed without documented due diligence. It then cut the penalty to $100 million on condition that the $800 million abatement award stands. If the abatement is reduced or eliminated, for example on appeal, the full $337.9 million penalty revives.

Where the money goes

The $800 million must be paid into a trust established by the state for the sole purpose of implementing the abatement plan, with governing documents subject to court approval and annual reports to the court on receipts, spending and outcomes. The plan covers treatment, harm reduction, prevention, and coordination and monitoring, and Albertsons has no role in running it. The court declined a separate restitution award. Attorney General Nick Brown said the result "will provide desperately needed resources to support treatment and prevent future crises".

Albertsons' response and the appeal question

Albertsons said in a statement reported by KOMO News that it is disappointed by the ruling, respectfully disagrees with its conclusions and "will evaluate all available options, including appeal". At trial, according to Reuters, its lawyers argued that it sold lawful drugs prescribed by doctors and that pharmacists should not second-guess a doctor without real reason to suspect a prescription. An appeal would face detailed bench-trial findings, unlike the jury verdicts in our piece on whether a jury verdict can be reversed.

How it fits the wider pharmacy opioid litigation

Most US pharmacy opioid claims have settled. Reuters puts nationwide opioid settlements at roughly $58 billion. According to Insurance Journal, CVS, Walmart and Walgreens began paying more than $13 billion after proposing settlements in late 2022, Kroger agreed in 2023 to pay up to $1.2 billion to states and local governments, and Albertsons announced a $774 million national settlement in April 2026, payable over nine years. Washington declined to join that Albertsons deal and went to trial instead, as it had with the three big distributors.

Washington opioid recovery	Amount
McKesson, Cardinal Health and AmerisourceBergen (May 2022, after trial began)	$518 million
CVS, Walgreens, Walmart, Teva and Allergan (December 2022)	Up to $434.4 million
Albertsons judgment (5 November 2026)	$900 million, plus fees and costs
Opioid recoveries by the Attorney General's Office since the crisis began, as stated on 5 November 2026	$2.17 billion

The distributor resolution came after the state rejected the national deal, which it said brought about $46 million more. The state's estimate for the five 2022 settlements included $110.6 million from CVS, $120.3 million from Walgreens and $62.6 million from Walmart.

What it means for retailers, pharmacies, insurers and boards

The Albertsons opioid lawsuit holds several lessons for chains, insurers and boards.

• Settlement terms are not a safe harbour. Albertsons cited injunctive terms in the Kroger, CVS, Walgreens and Walmart settlements. The court gave them no weight as evidence of the legal standard: consent decrees reflect a bargain, not the law.
• Documentation is the defence. The penalty was counted prescription by prescription, from Albertsons' own dispensing data. Pharmacies need records showing each red flag and how it was resolved.
• Staffing is a compliance issue. The court found understaffing contributed to the failures, and the injunction now requires staffing sufficient for pharmacists to review and document.
• Insurance may not respond. In August 2025 Delaware's Supreme Court held that CVS's general liability insurers did not owe cover because the government suits sought economic losses, not damages for bodily injury, following its 2022 Rite Aid decision, as Insurance Journal reported. Wording and timing matter, as our guide to claims-made vs occurrence policies explains.
• Disclosure is tested. The court quoted Albertsons' Form 10-K statement that such claims would not have a material adverse effect, and weighed $83.2 billion of net sales and other revenue and $1.49 billion of share buybacks when setting penalties. Boards should expect ability to pay to be examined.

Companies facing similar exposure can find dispute resolution lawyers, product liability specialists and insurance advisers in the United States through our directory.

Frequently asked questions

How much must Albertsons pay Washington?

$900 million: $800 million to fund an opioid abatement plan and $100 million in Consumer Protection Act penalties, plus the state's costs and attorneys' fees. If the abatement award is reduced or overturned, the penalty rises to $337,921,650. Albertsons Companies and Safeway are jointly and severally liable for most of it.

Was the Albertsons opioid lawsuit decided by a jury?

No. King County Superior Court Judge Janet Helson heard the case without a jury over nine weeks, from 13 July to 14 September 2026, and issued written findings of fact, conclusions of law and final judgment on 5 November 2026.

What legal claims succeeded against Albertsons?

Two: statutory public nuisance under RCW 7.48.120 and unfair practices under the Consumer Protection Act. The court found Albertsons breached federal and state duties to resolve red flags and stop suspicious orders, and was a substantial factor in Washington's opioid oversupply.

Where will the $800 million go?

Into a trust set up by the state solely to implement the abatement plan, covering treatment, harm reduction, prevention and coordination. The court must approve the trust's governing documents and receive annual reports on receipts, spending and outcomes. Albertsons has no role in running it.

Did Washington join Albertsons' national opioid settlement?

No. Albertsons announced a national settlement of about $774 million in April 2026, but Washington chose to continue its own case. The court refused to reduce the award for other companies' settlements, saying it had already ordered Albertsons to pay only a fraction of the abatement cost.

Sources

1. King County Superior Court, State of Washington v. Rite Aid Corp. et al., No. 22-2-20910-1 SEA, Findings of Fact and Conclusions of Law, 5 November 2026: agportal-s3bucket.s3.us-west-2.amazonaws.com
2. Washington State Office of the Attorney General, "Washington wins $900 million verdict against Albertsons for fueling opioid crisis", 5 November 2026: atg.wa.gov
3. Revised Code of Washington 7.48.120, Nuisance defined: app.leg.wa.gov
4. Revised Code of Washington 19.86.140, Civil penalties: app.leg.wa.gov
5. Washington State Office of the Attorney General, "AG Ferguson: Opioid distributors to pay $518 million to Washington", 3 May 2022: atg.wa.gov
6. Washington State Office of the Attorney General, Opioid Pharmacy and Manufacturer Settlements: atg.wa.gov
7. KOMO News, "Judge orders Albertsons to pay $900 million in Washington opioid case", 5 November 2026: komonews.com
8. Reuters (Nate Raymond), "Albertsons must pay $900 million for fueling opioid epidemic in Washington state, judge rules", 5 November 2026, via Yahoo Finance: ca.finance.yahoo.com
9. Insurance Journal, "Albertsons Reaches $774 Million Opioid Accord, Records Loss", 14 April 2026: insurancejournal.com
10. Insurance Journal, "CVS Not Covered by Insurance for Opioid Lawsuits, Delaware Supreme Court Rules", 19 August 2025: insurancejournal.com

About this article

Researched and written by The Corporate INTL Newsroom from the King County Superior Court's findings of fact, conclusions of law and judgment, the Washington Attorney General's announcements, Washington statutes and contemporaneous reporting. It is general information, not legal advice. Last reviewed 6 November 2026. For more analysis visit our newsroom or subscribe to our newsletter.